# Daily Briefing

*Generated: 2026-02-18 12:14 UTC*

1. **Market Overview**: Major U.S. indexes posted modest gains amid AI uncertainty, with the Nasdaq Composite, S&P 500, and Dow Jones Industrial Average each gaining 0.1%. The VIX volatility index remains elevated at 20.24. In the crypto market, Bitcoin's price is down, trading at $67,564, with a 24-hour change of -0.71% and a 7-day change of 1.61%. Ethereum's price is $1,984.04, with a 24-hour change of 0.54% and a 7-day change of 2.43%.

2. **Tech & AI**: Significant AI developments include Merck and Mayo Clinic's collaboration on AI-enabled drug discovery, the emergence of AI-powered digital pathology tools for personalized cancer treatment, and the launch of NOW // AI, a simulation program for AI risk management. Additionally, there are concerns about AI hype vs. reality, with a Columbia University AI administrator expressing skepticism about AI capabilities.

3. **Gaming & Entertainment**: There is no notable gaming news in the provided data.

4. **Key Insights**:
* The market is experiencing volatility due to AI uncertainty, with software stocks facing significant selling pressure while mega-cap AI infrastructure companies hold steady.
* Regulatory developments in the crypto space include the SEC's approval of the DTC to proceed with tokenizing stocks on blockchain.
* AI is being increasingly used in various industries, including healthcare, with the development of AI-powered digital pathology tools.
* There is a growing concern about the gap between AI hype and reality, with some experts expressing skepticism about AI capabilities.
* The NAHB Housing Market Index fell to 36 in February, missing consensus expectations and signaling continued weakness in the housing sector.

5. **Watch List**: 
* Nvidia's earnings report scheduled for February 25, which will be closely watched for guidance on the AI sector.
* The SEC's approval of the DTC to proceed with tokenizing stocks on blockchain and its potential impact on the financial industry.
* The development of AI-powered digital pathology tools and their potential to advance personalized oncology care.
* The market's reaction to AI uncertainty and its potential impact on the stock market.
* The housing market, which continues to show weakness, with the NAHB Housing Market Index falling to 36 in February.